Yamamoto, Naoki

Publishing since 1961 (Dinosaur)

Has published 849 publications in 50 years

Number of publications published per year by Yamamoto, Naoki. (Source : PubMed)

Distribution of publications types for Yamamoto, Naoki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Aoki K, Yano K, Suzuki A, Kawamura S, Sakurai N, Suda K, Kurabayashi A, Suzuki T, Tsugane T, Watanabe M, Ooga K, Torii M, Narita T, Shin-I T, Kohara Y, Yamamoto N, Takahashi H, Watanabe Y, Egusa M, Kodama M, Ichinose Y, Kikuchi M, Fukushima S, Okabe A, Arie T, Sato Y, Yazawa K, Satoh S, Omura T, Ezura H, Shibata D. Large-scale analysis of full-length cDNAs from the tomato (Solanum lycopersicum) cultivar Micro-Tom, a reference system for the Solanaceae genomics.  BMC Genomics  2010;11;1  
•  Kajihara Y, Yamamoto N, Okamoto R, Hirano K, Murase T. Chemical synthesis of homogeneous glycopeptides and glycoproteins.  Chem Rec  2010  
•  Ono A, Naito T, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Kaira K, Igawa S, Shukuya T, Tamiya A, Kaira R, Endo M, Yamamoto N. Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer.  Int. J. Clin. Oncol.  2010  
•  Yamada T, Tsuchiya K, Kato S, Kamei S, Taniguchi M, Takeuchi T, Yamamoto N, Ehara H, Deguchi T. A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients.  Int. J. Clin. Oncol.  2010  
•  Shukuya T, Takahashi T, Nakamura Y, Yamamoto N. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]  Gan To Kagaku Ryoho  2010;37;3  
•  Hamamoto I, Yamamoto N. [Progress of basic research on HIV/AIDS: HIV entry mechanism: comparison with influenza virus]  Nippon Rinsho  2010;68;3  
•  Haga S, Nagata N, Okamura T, Yamamoto N, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.  Antiviral Res.  2010;85;3  
•  Mizuno O, Kawamoto H, Yamamoto N, Horiguchi S, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ishida E, Ogawa T, Okada H, Yamamoto K. Single-Pattern Convergence of K-ras Mutation Correlates With Surgical Indication of Intraductal Papillary Mucinous Neoplasms.  Pancreas  2010  
•  Kasahara K, Souri M, Kaneda M, Miki T, Yamamoto N, Ichinose A. Impaired clot retraction in factor XIII A subunit-deficient mice.  Blood  2010;115;6  
•  Takeda K, Hida T, Sato T, Ando M, Seto T, Satouchi M, Ichinose Y, Katakami N, Yamamoto N, Kudoh S, Sasaki J, Matsui K, Takayama K, Kashii T, Iwamoto Y, Sawa T, Okamoto I, Kurata T, Nakagawa K, Fukuoka M. Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203).  J. Clin. Oncol.  2010;28;5  

[ See timeline ] [ See all publications ]